Table 2.
Disease Activity | Pre-Transfer | Post-Transfer | P value |
Median (range) SLEDAI score* | 4 (0–16) | 4 (0–20) | 0.3 |
Disease activity** | |||
None | 12 (80) | 10 (67) | |
Mild/moderate | 2 (13) | 4 (27) | 0.16 |
Severe | 1 (7) | 1 (7) | |
Number of Hospitalizations* | |||
Total | 32 | 6 | 0.017 |
Scheduled | 21 | 2 | 0.03 |
Flare associated | 8 | 4 | 0.26 |
Steroid Dosing | |||
Median prednisone dose at last visit, mg (range) | 5 (0–40) | 2 (0–20) | 0.004 |
Median peak prednisone dose, mg (range) | 10 (0–60) | 5 (0–60) | 0.059 |
IV methylprednisolone, No (%) | 3 (10) | 4 (13) | 0.99 |
* Systemic Lupus Erythematosus (n = 16)
**MCTD, APLS, Vasculitis, Spondylarthropathy (n = 15)
IV = Intravenous